Balaxi Pharmaceuticals Limited (NSE:BALAXI)
India · Delayed Price · Currency is INR 22.75
+0.87 (3.98%)
Apr 7, 2026, 3:29 PM IST
Balaxi Pharmaceuticals Market Cap
Balaxi Pharmaceuticals has a market cap or net worth of 1.27 billion as of April 7, 2026. Its market cap has decreased by -65.76% in one year.
Market Cap
1.27B
Enterprise Value
1.44B
Revenue
2.76B
Ranking
n/a
PE Ratio
13.14
Stock Price
22.75
Market Cap Chart
Since December 1, 2015, Balaxi Pharmaceuticals's market cap has increased from 41.50M to 1.27B, an increase of 2,952.01%. That is a compound annual growth rate of 39.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 1.21B | -18.57% |
| Dec 31, 2025 | 1.48B | -59.70% |
| Dec 31, 2024 | 3.68B | -16.38% |
| Dec 29, 2023 | 4.40B | -27.68% |
| Dec 30, 2022 | 6.09B | 18.63% |
| Dec 31, 2021 | 5.13B | -21.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anthem Biosciences | 371.08B |
| OneSource Specialty Pharma | 160.99B |
| Concord Biotech | 107.24B |
| Blue Jet Healthcare | 61.99B |
| Supriya Lifescience | 49.27B |
| Zota Health Care | 37.51B |
| Dishman Carbogen Amcis | 23.13B |
| Panacea Biotec | 19.81B |